Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms

被引:18
|
作者
Autret, A. [1 ]
Roux, S.
Rimbaux-Lepage, S. [1 ]
Valade, D. [2 ]
Debiais, S. [1 ]
机构
[1] Univ Tours, Dept Neurol, CHRU Tours, F-37000 Tours, France
[2] Hop Lariboisiere, Ctr Urgence Cephalees, F-75475 Paris 10, France
来源
JOURNAL OF HEADACHE AND PAIN | 2010年 / 11卷 / 03期
关键词
Psychopathology; Quality of life; Chronic daily headache; Migraine symptoms; Tension type headache symptoms; PSYCHIATRIC COMORBIDITY; GENERAL-POPULATION; RISK-FACTORS; SF-36; PREVALENCE; QUESTIONNAIRE; EPIDEMIOLOGY; DEPRESSION; DISORDERS; CRITERIA;
D O I
10.1007/s10194-010-0208-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study is to compare the psychopathology and the quality of life of chronic daily headache patients between those with migraine headache and those with tension-type headache. We enrolled 106 adults with chronic daily headache (CDH) who consulted for the first time in specialised centres. The patients were classified according to the IHS 2004 criteria and the propositions of the Headache Classification Committee (2006) with a computed algorithm: 8 had chronic migraine (without medication overuse), 18 had chronic tension-type headache (without medication overuse), 80 had medication overuse headache and among them, 43 fulfilled the criteria for the sub-group of migraine (m) MOH, and 37 the subgroup for tension-type (tt) MOH. We tested five variables: MADRS global score, HAMA psychic and somatic sub-scales, SF-36 psychic, and somatic summary components. We compared patients with migraine symptoms (CM and mMOH) to those with tension-type symptoms (CTTH and ttMOH) and neutralised pain intensity with an ANCOVA which is a priori higher in the migraine group. We failed to find any difference between migraine and tension-type groups in the MADRS global score, the HAMA psychological sub-score and the SF36 physical component summary. The HAMA somatic anxiety subscale was higher in the migraine group than in the tension-type group (F(1,103) = 10.10, p = 0.001). The SF36 mental component summary was significantly worse in the migraine as compared with the tension-type subgroup (F(1,103) = 5.758, p = 0.018). In the four CDH subgroups, all the SF36 dimension scores except one (Physical Functioning) showed a more than 20 point difference from those seen in the adjusted historical controls. Furthermore, two sub-scores were significantly more affected in the migraine group as compared to the tension-type group, the physical health bodily pain (F(1,103) = 4.51, p = 0.036) and the mental health (F(1,103) = 8.17, p = 0.005). Considering that the statistic procedure neutralises the pain intensity factor, our data suggest a particular vulnerability to somatic symptoms and a special predisposition to develop negative pain affect in migraine patients in comparison to tension-type patients.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [21] Economic burden of chronic daily headache in France
    Lanteri-Minet, M.
    Lucas, C.
    Duru, G.
    Auray, J-P
    Gaudin, A. F.
    El-Hasnaoui, A.
    CEPHALALGIA, 2009, 29 : 60 - 60
  • [22] Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C-dAS)
    Lipton, Richard B.
    Manack, Aubrey
    Ricci, Judith A.
    Chee, Elsbeth
    Turkel, Catherine C.
    Winner, Paul
    HEADACHE, 2011, 51 (05): : 693 - 706
  • [23] Burden of Episodic Migraine, Chronic Migraine, and Medication Overuse Headache in Alberta
    Mcmullen, Suzanne
    Graves, Erin
    Ekwaru, Paul
    Pham, Tram
    Mayer, Michelle
    Ladouceur, Marie-Pier
    Hubert, Martine
    Bougie, Joanna
    Amoozegar, Farnaz
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024, 51 (04) : 535 - 545
  • [24] From migraine to chronic daily headache: The biological basis of headache transformation
    Meng, Ian D.
    Cao, Ling
    HEADACHE, 2007, 47 (08): : 1251 - 1258
  • [25] Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
    Couch, James R.
    HEADACHE, 2011, 51 (01): : 33 - 51
  • [26] Olanzapine in the treatment of refractory migraine and chronic daily headache
    Silberstein, SD
    Peres, MFP
    Hopkins, MM
    Shechter, AL
    Young, WB
    Rozen, TD
    HEADACHE, 2002, 42 (06): : 515 - 518
  • [27] Botox Treatment for Migraine and Chronic Daily Headache in Adolescents
    Chan, Valerie W.
    McCabe, E. Jane
    MacGregor, Daune L.
    JOURNAL OF NEUROSCIENCE NURSING, 2009, 41 (05) : 235 - 243
  • [28] Chronic migraine with daily headache. Literature review
    Martinez-Pias, Enrique
    Garcia-Azorin, David
    Trigo-Lopez, Javier
    Sierra, Alvaro
    Guerrero-Peral, Angel L.
    REVISTA DE NEUROLOGIA, 2021, 72 (04) : 133 - 140
  • [30] Chronic daily headache with analgesic overuse -: Epidemiology and impact on quality of life
    Colás, R
    Muñoz, P
    Temprano, R
    Gómez, C
    Pascual, J
    NEUROLOGY, 2004, 62 (08) : 1338 - 1342